FVIII Immunity : early events and tolerance mechanisms to FVIII
Among the complications of current treatments for hemophilia A, the development of anti-FVIII antibodies including “FVIII inhibitors” remains the major clinical problem in treating hemophiliacs. Factor VIII inhibitors work through neutralizing the coagulation cofactor activity of the infused FVIII a...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en en |
| Published: |
2008
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/1974/1356 |